Taiwan FDA registration ae680624f062231c967512727b553602
CJ Rapitest PSA test kit
TW: 啟哲速測家前列腺特異性抗原檢測試劑組
Taiwan·Risk Class 2·MD·Qizhe Biotechnology Co., Ltd·Registered Apr 14, 2017 – Apr 14, 2022ExpiredRegistration details
- Analysis ID
- ae680624f062231c967512727b553602
- License Form
- Ministry of Health Medical Device Manufacturing No. 005599
Company information
- Manufacturer
- Qizhe Biotechnology Co., Ltd
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Qizhe Biotechnology Co., Ltd
Product details
- Intended Use
- Qualitative detection of prostate-specific antigen (PSA) in human serum.
- Product Type (Level 1)
- C Immunology and microbiology devices
- Product Type (Level 2)
- C6010 Tumor-associated antigen immunoassay system
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Apr 14, 2017
- Expiry Date
- Apr 14, 2022
About this record
Access comprehensive regulatory information for CJ Rapitest PSA test kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ae680624f062231c967512727b553602 and manufactured by Qizhe Biotechnology Co., Ltd. The authorized representative in Taiwan is Qizhe Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices